Journal
IET SYSTEMS BIOLOGY
Volume 6, Issue 1, Pages 22-33Publisher
INST ENGINEERING TECHNOLOGY-IET
DOI: 10.1049/iet-syb.2010.0052
Keywords
-
Categories
Funding
- Shanghai Institutes for Biological Sciences (SIBS)
- Chinese Academy of Sciences (CAS) [2009CSP002]
- SIBS of CAS [2011KIP203]
- National Natural Science Foundation of China (NSFC) [31100949, 61134013, 10801131, 60873205, 11131009, 91029301]
- Shanghai Pujiang Program
- Shanghai NSF [11ZR1443100]
- JSPS
- SRF for ROCS, SEM
- Shanghai Key Laboratory of Intelligent Information Processing [IIPL-2010-008]
Ask authors/readers for more resources
Complex diseases are commonly believed to be caused by the breakdown of several correlated genes rather than individual genes. The availability of genome-wide data of high-throughput experiments provides us with new opportunity to explore this hypothesis by analysing the disease-related biomolecular networks, which are expected to bridge genotypes and disease phenotypes and further reveal the biological mechanisms of complex diseases. In this study, the authors review the existing network biology efforts to study complex diseases, such as breast cancer, diabetes and Alzheimer's disease, using high-throughput data and computational tools. Specifically, the authors categorise these existing methods into several classes based on the research topics, that is, disease genes, dysfunctional pathways, network signatures and drug-target networks. The authors also summarise the pros and cons of those methods from both computation and application perspectives, and further discuss research trends and future topics of this promising field.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available